Company

NeuroPace, Inc.

NeuroPace develops the RNS System, an implanted treatment for drug-resistant epilepsy.

About

Founded in 1999 and based in Mountain View, US, NeuroPace develops the RNS System, which delivers personalized treatment for adults with drug-resistant epilepsy. The company was co-founded by Joel Becker and Michael Favet. It raised USD 102 mn through its IPO on April 21, 2021.

5Funding rounds

13Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in